FUTURELYTICS Trademark

Trademark Overview


On Wednesday, April 3, 2019, a trademark application was filed for FUTURELYTICS with the United States Patent and Trademark Office. The USPTO has given the FUTURELYTICS trademark a serial number of 88369774. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 20, 2023. This trademark is owned by Roche Molecular Systems, Inc.. The FUTURELYTICS trademark is filed in the Computer & Software Products & Electrical & Scientific Products and Computer & Software Services & Scientific Services categories with the following description:

Downloadable computer databases containing information in the field of genomics, cancer research and cancer treatments; downloadable computer software for accessing, organizing, interpreting and analyzing information from databases in the fields of genomics, cancer research and cancer treatments; laboratory apparatus for sequencing of genomic DNA; downloadable computer databases, in particular biomedical computer databases containing information about clinical, molecular, scientific and patient specific data, in particular for the integration, interpretation and analysis of cancer genomic information, biomarker information; downloadable computer software for authorizing access to these biomedical databases, in particular application software, interface software, software drives, data communication software and interactive computer software

Data collection for analytical and clinical purposes, in particular the collection and systematic sorting of specific molecular, genomic and/or clinical data relating to genomic changes, namely, cancer genomic changes, of an individual, namely, of a cancer patient; providing scientific information through the collection and analysis of genetic information and information regarding the treatment of cancer and other diseases and disorders; data collection for analytical purposes, in particular the collection of mathematical and statistical data, clinical data, genomic data and data of clinical studies relating to individuals' clinical responses to drug treatments and treatment regimes; providing scientific advise in the fields of cancer biology, cancer treatment, pharmaceutical side effects, genomics, cancer medicine and translational medicine; providing scientific analysis and analysis services in the field of next generation sequencing (NGS), namely, the analysis and interpretation of ...
futurelytics

General Information


Serial Number88369774
Word MarkFUTURELYTICS
Filing DateWednesday, April 3, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 20, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 17, 2019

Trademark Statements


Goods and ServicesDownloadable computer databases containing information in the field of genomics, cancer research and cancer treatments; downloadable computer software for accessing, organizing, interpreting and analyzing information from databases in the fields of genomics, cancer research and cancer treatments; laboratory apparatus for sequencing of genomic DNA; downloadable computer databases, in particular biomedical computer databases containing information about clinical, molecular, scientific and patient specific data, in particular for the integration, interpretation and analysis of cancer genomic information, biomarker information; downloadable computer software for authorizing access to these biomedical databases, in particular application software, interface software, software drives, data communication software and interactive computer software
Pseudo MarkFUTURE LYTICS
Goods and ServicesData collection for analytical and clinical purposes, in particular the collection and systematic sorting of specific molecular, genomic and/or clinical data relating to genomic changes, namely, cancer genomic changes, of an individual, namely, of a cancer patient; providing scientific information through the collection and analysis of genetic information and information regarding the treatment of cancer and other diseases and disorders; data collection for analytical purposes, in particular the collection of mathematical and statistical data, clinical data, genomic data and data of clinical studies relating to individuals' clinical responses to drug treatments and treatment regimes; providing scientific advise in the fields of cancer biology, cancer treatment, pharmaceutical side effects, genomics, cancer medicine and translational medicine; providing scientific analysis and analysis services in the field of next generation sequencing (NGS), namely, the analysis and interpretation of genomic data obtained from cancer patients, providing scientific information on individuals' genomic changes that contribute to a unique cancer disease; providing research information about drug safety and drug compatibility in relation to cancer therapy and the treatment of individuals; scientific consulting services in the fields of pharmaceuticals and genetics, in particular conducting scientific research in drug safety and dosage assessment and drug compatibility studies in the field of cancer treatment therapy for others; providing a website for electronic storage of medical data and information for physicians and healthcare professionals; providing an online, non-downloadable computer software platform for purposes of storing and providing information about an individual's cancer profile and genomic changes to enable physicians and healthcare professionals to optimize treatment in clinical practice; providing an on-line searchable database in the field of clinical, molecular, scientific and patient specific data, in particular for the integration, interpretation and analysis of cancer genomic information and biomarker information for scientific research purposes

Classification Information


International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateMonday, April 22, 2019
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, April 22, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRoche Molecular Systems, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPLEASANTON, CA 94588

Party NameRoche Molecular Systems, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPleasanton, CA 94588

Trademark Events


Event DateEvent Description
Monday, March 20, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 20, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 8, 2022SOU EXTENSION 5 GRANTED
Wednesday, July 27, 2022SOU EXTENSION 5 FILED
Monday, August 8, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 27, 2022SOU TEAS EXTENSION RECEIVED
Thursday, January 27, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 25, 2022SOU EXTENSION 4 GRANTED
Tuesday, January 25, 2022SOU EXTENSION 4 FILED
Tuesday, January 25, 2022SOU TEAS EXTENSION RECEIVED
Thursday, July 15, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 13, 2021SOU EXTENSION 3 GRANTED
Tuesday, July 13, 2021SOU EXTENSION 3 FILED
Tuesday, July 13, 2021SOU TEAS EXTENSION RECEIVED
Saturday, January 30, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 28, 2021SOU EXTENSION 2 GRANTED
Thursday, January 28, 2021SOU EXTENSION 2 FILED
Thursday, January 28, 2021SOU TEAS EXTENSION RECEIVED
Monday, October 19, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 19, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 19, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 19, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 19, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, August 13, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 11, 2020SOU EXTENSION 1 GRANTED
Tuesday, August 11, 2020SOU EXTENSION 1 FILED
Tuesday, August 11, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, February 11, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 17, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 17, 2019PUBLISHED FOR OPPOSITION
Wednesday, November 27, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 27, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 27, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 11, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 11, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 11, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 10, 2019ASSIGNED TO LIE
Friday, October 4, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 2, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 2, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 8, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 8, 2019NON-FINAL ACTION E-MAILED
Monday, July 8, 2019NON-FINAL ACTION WRITTEN
Thursday, June 13, 2019ASSIGNED TO EXAMINER
Monday, April 22, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, April 6, 2019NEW APPLICATION ENTERED